Prof Henrik Zetterberg

Group Leader

Pioneering the development of fluid biomarkers for dementia

Biography

With a background in molecular biology and medicine, Prof Henrik Zetterberg has spent the past 15 years focusing on the development of biomarkers for Alzheimer’s disease and other brain disorders - becoming a world expert in the process. He has published more than 1100 scientific articles and has received numerous awards.

News

Key publications

Journal of neurology
Published

Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 months

Authors
Nina Gleisner, Francisco Meda, Magnus Johnsson, Igal Rosenstein, Ellen Alpsten, Lenka Novakova, Jan Lycke, Henrik Zetterberg, Hlin Kvartsberg, Brynhildur Hafsteinsdottir, Markus Axelsson
Cerebrospinal fluid alpha-internexin concentrations measured in patients with Guillain-Barré syndrome: a possible prognostic biomarker for disability at 12 months
Alzheimer's research & therapy
Published

Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's disease

Authors
Valentina Di Caro, Eunah Cho, Jill Thiel, Britney N Lizama, Marleen J A Koel-Simmelink, Kiran Pandey, Duc Duong, Nicholas T Seyfried, Michael Grundman, Charlotte E Teunissen, Henrik Zetterberg, Kaj Blennow, Anthony O Caggiano, Mary E Hamby
Impact of zervimesine on the neuroinflammatory biomarker GFAP and related proteomic molecular correlates in plasma of participants from a phase 2 clinical trial in Alzheimer's disease
Communications medicine
Published

Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans

Authors
Bryan J Neth, Kevin Huynh, Corey Giles, Tingting Wang, Natalie A Mellett, Thy Duong, Colette Blach, Leyla Schimmel, Thomas C Register, Kaj Blennow, Henrik Zetterberg, Richa Batra, Annalise Schweickart, Amanda Hazel Dilmore, Cameron Martino, Matthias Arnold, Jan Krumsiek, Xianlin Han, Pieter C Dorrestein, Rob Knight, Peter J Meikle, Suzanne Craft, Rima Kaddurah-Daouk
Author Correction: Consuming a modified Mediterranean ketogenic diet reverses the peripheral lipid signature of Alzheimer's disease in humans
JAMA network open
Published

Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients: The Phase 2 MARBLE Randomized Clinical Trial

Authors
Noah J Timko, Mary Cooter Wright, Melody R Smith, Piper C Boykin, Jacqueline M Emerson, Marty G Woldorff, Sarada Eleswarpu, J Taylor Herbert, Eugene W Moretti, Michael J Devinney, Chakib M Ayoub, Frank W Rockhold, David Ryu, Ayesha Syed, Keith W VanDusen, Thomas Bunning, Bethany J Hsia, Michael P Bolognesi, William A Jiranek, Henrik Zetterberg, Kaj Blennow, Janet L Huebner, Zhong Li, Tyler H Reekes, Jeffrey N Browndyke, Daniel T Laskowitz, Miles Berger, MARBLE Study Investigators
Apolipoprotein E Mimetic Peptide CN-105 and Postoperative Delirium in Older Patients: The Phase 2 MARBLE Randomized Clinical Trial

Zetterberg Lab

Explore the work of the Zetterberg Lab, pioneering the development of fluid biomarkers for dementia

Zetterberg Lab